Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Juan De la Cámara"'
Autor:
Nieves Martínez-Lago, Teresa Calleja Chucla, Beatriz Alonso De Castro, Rafael Varela Ponte, Cristina Reboredo Rendo, Martin Igor Gomez-Randulfe Rodriguez, Sofia Silva Diaz, Begoña Graña Suarez, Juan de la Cámara Gomez, Fernando Busto Fernández, María Mateos Salvador, Margarita Reboredo Lopez
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract We evaluated the efficacy and safety of trifluridine/tipiracil (TAS-102) plus bevacizumab in treating refractory metastatic colorectal cancer (mCRC) in a retrospective, observational study. Patients refractory or intolerant to standard thera
Externí odkaz:
https://doaj.org/article/c57ed14ff76941199d651c58407ca464
Autor:
Ana Fernández Montes, Alberto Carmona-Bayonas, Paula Jimenez-Fonseca, Francisca Vázquez Rivera, Nieves Martinez Lago, Marta Covela Rúa, Antía Cousillas Castiñeiras, Paula Gonzalez Villarroel, Juan De la Cámara Gómez, José Carlos Méndez Méndez, Carmen Carriles Fernández, Manuel Sanchez Cánovas, Teresa Garcia García
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Trifluridine/tipiracil increases overall survival (OS) in patients with refractory, metastatic colorectal cancer (mCRC). A post hoc exploratory analysis of the RECOURSE randomized clinical trial (RCT) established two categories, a good progn
Externí odkaz:
https://doaj.org/article/79955248229f4b8ab9ff4d86bc53b994
Autor:
Nieves Martínez-Lago, Ana Fernández-Montes, Marta Covela, Elena M. Brozos, Juan De la Cámara, José C. Méndez Méndez, Mónica Jorge-Fernández, Antía Cousillas Castiñeiras, Cristina Reboredo, David Arias Ron, María L. Pellón Augusto, Paula González Villarroel, Begoña Graña, Mercedes Salgado Fernández, Alberto Carral Maseda, Francisca Vázquez Rivera, Sonia Candamio Folgar, Margarita Reboredo López, On behalf of the Galician Research Group on Digestive Tumors (GITuD)
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Outcomes are poorer in metastatic colorectal cancer (mCRC) patients with BRAF V600E mutations than those without it, but the effect of these mutations on treatment response is unclear. This real-world study assessed the effects of
Externí odkaz:
https://doaj.org/article/0205a0ed5fdf486f96be2430c7159205
Autor:
Ana Fernández, Mercedes Salgado, Adelaida García, Elvira Buxò, Ruth Vera, Jorge Adeva, Paula Jiménez-Fonseca, Guillermo Quintero, Cristina Llorca, Mamen Cañabate, Luis Jesús López, Andrés Muñoz, Patricia Ramírez, Paula González, Carlos López, Margarita Reboredo, Elena Gallardo, Manuel Sanchez-Cánovas, Javier Gallego, Carmen Guillén, Nuria Ruiz-Miravet, Víctor Navarro-Pérez, Juan De la Cámara, Inmaculada Alés-Díaz, Roberto Antonio Pazo-Cid, Alberto Carmona-Bayonas
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Treatment with nab-paclitaxel plus gemcitabine increases survival in patients with metastatic pancreatic cancer. However, the assessment of treatment efficacy and safety in non-selected patients in a real-life setting may provide
Externí odkaz:
https://doaj.org/article/9fb8c852c86a46288b6abc44c57cd6fc
Autor:
T. García, Juan de la Cámara Gómez, Alberto Carmona-Bayonas, Marta Covela Rúa, Francisca Vázquez Rivera, Paula Jiménez-Fonseca, Manuel Cánovas, Ana Montes, Carmen Carriles Fernández, Paula Gonzalez Villarroel, Nieves Martinez Lago, Antía Cousillas Castiñeiras, J. Méndez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
Scientific Reports
Trifluridine/tipiracil increases overall survival (OS) in patients with refractory, metastatic colorectal cancer (mCRC). A post hoc exploratory analysis of the RECOURSE randomized clinical trial (RCT) established two categories, a good prognosis corr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9ba7e763c6b00042f89c47722807250
https://doaj.org/article/79955248229f4b8ab9ff4d86bc53b994
https://doaj.org/article/79955248229f4b8ab9ff4d86bc53b994
Autor:
Juan De la Cámara De las Heras, Beatriz Muñoz Martín, Cristina Escudero, Villegas-Tripiana Irene, Mª Carmen Salcedo-Sánchez
Publikováno v:
Revista Española de Documentación Científica. 45:e341
La pandemia de COVID-19 ha afectado al funcionamiento de las bibliotecas de todos los ámbitos, incluidas las sanitarias. El objetivo de este estudio es analizar su impacto en las bibliotecas especializadas de Ciencias de la Salud de hospitales públ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cea0e531f00bc9ce3103c83d88148fc
https://doi.org/10.3989/redc.2022.4.1920
https://doi.org/10.3989/redc.2022.4.1920
Autor:
Montes, Ana Fernández, Martinez-Lago, Nieves, Gomez, Juan de la Cámara, Vázquez, Elena María Brozos, Folgar, Sonia Candamio, Campos, Marta Carmona, Castiñeiras, Antía Cousillas, Rúa, Marta Covela, Martín, Elena Gallardo, Villarroel, Paula González, Suarez, Begoña Graña, Fernández, Mónica Jorge, Augusto, María Luz Pellón, Aldana, Guillermo Quintero, Reinoso, Carlos Romero, Fernández, Mercedes Salgado, Rivera, Francisca Vázquez, Álvarez, Ana Ayuso, Culqui, Dante R., Méndez, José Carlos Méndez, Group, RIGhT-sens Working Group RIGhT-sens Working
Publikováno v:
Healthcare
Volume 9
Issue 6
Healthcare, Vol 9, Iss 665, p 665 (2021)
Repisalud
Instituto de Salud Carlos III (ISCIII)
Volume 9
Issue 6
Healthcare, Vol 9, Iss 665, p 665 (2021)
Repisalud
Instituto de Salud Carlos III (ISCIII)
Background: In recent years, abundant scientific evidence has been generated based on clinical trials (CT) in the field of oncology. In spite of this, there are still major disagreements among the group when it comes to establishing a treatment and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2286280bb7575ab41877fefa5864a4d
Autor:
Mónica Jorge Fernández, Maria Luz Pellon Augusto, J. Méndez, Ana Montes, Juan de la Cámara Gómez, Mercedes Salgado Fernández, Margarita Reboredo Lopez, Nieves Martinez Lago, Guillermo Alfonso Quintero Aldana, Paula González Villaroel, Marta Covela Rúa, Jesús García Gómez, Begoña Graña Suárez
Publikováno v:
Cancer Medicine
Purpose The phase III VELOUR trial demonstrated efficacy with combined FOLFIRI‐aflibercept in patients with metastatic colorectal cancer previously treated with oxaliplatin with or without bevacizumab versus placebo. The effect of FOLFIRI‐afliber
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae65e3bd50f9a60867938d42f4c8e9d0
http://europepmc.org/articles/PMC6434192
http://europepmc.org/articles/PMC6434192
Autor:
Carlos Romero Reinoso, Paula Gonzalez Villarroel, Juan de la Cámara Gómez, Ana Montes, Mónica Jorge Fernández, Jose Carlos Mendez, Manuel Valladares Ayerbes, Margarida Reboredo López, Mari Luz Pellón Augusto, Mercedes Salgado Fernández, Manuel Ramos Vázquez, Guillermo Alfonso Quintero Aldana, Marta Covela Rúa
Publikováno v:
Journal of geriatric oncology. 11(8)
Background Despite the high morbidity and mortality of metastatic colorectal cancer (mCRC) in older patients, they have been underrepresented in clinical trials and their optimal treatment is yet to be determined. This open-label phase II study evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd82eb8a09073d05b0cb643d8f487b23
https://pubmed.ncbi.nlm.nih.gov/34507891
https://pubmed.ncbi.nlm.nih.gov/34507891
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.